Harvard Women's Health Watch

Two osteoporosis drugs better than one

A combination of two osteoporosis drugs-denosumab (Prolia) and teriparatide (Forteo)-increases bone mineral density in women at risk for fractures better than either drug alone.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »